CSN Login
Members Online: 12

Drug Cuts Death Risk for Melanoma Patients With BRAF Mutation

Posts: 507
Joined: Apr 2010

stumbled across this not sure if it is relitive to thyroid cancer BRAF mutation but thought this might be a good read

Aug. 17, 2011 -- The FDA today approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF V600E mutation.


any increase of survivaly rate of any cancer is happy

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network